FRINK Linked Data Fragments server

Matches in Wikidata for { <http://www.wikidata.org/entity/Q94147595> ?p ?o ?g. }

• Q94147595 description "2018 nî lūn-bûn" @default.
• Q94147595 description "2018 թվականի նոյեմբերի 5-ին հրատարակված գիտական հոդված" @default.
• Q94147595 description "2018年の論文" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年学术文章" @default.
• Q94147595 description "2018年學術文章" @default.
• Q94147595 description "2018年學術文章" @default.
• Q94147595 description "2018年學術文章" @default.
• Q94147595 description "2018年學術文章" @default.
• Q94147595 description "2018年學術文章" @default.
• Q94147595 description "2018년 논문" @default.
• Q94147595 description "article científic" @default.
• Q94147595 description "article scientific" @default.
• Q94147595 description "article scientifique" @default.
• Q94147595 description "articol științific" @default.
• Q94147595 description "articolo scientifico" @default.
• Q94147595 description "artigo científico" @default.
• Q94147595 description "artigo científico" @default.
• Q94147595 description "artigo científico" @default.
• Q94147595 description "artikel ilmiah" @default.
• Q94147595 description "artikull shkencor" @default.
• Q94147595 description "artikulong pang-agham" @default.
• Q94147595 description "artykuł naukowy" @default.
• Q94147595 description "artículo científico publicado en 2018" @default.
• Q94147595 description "artículu científicu" @default.
• Q94147595 description "bilimsel makale" @default.
• Q94147595 description "bài báo khoa học" @default.
• Q94147595 description "naučni članak" @default.
• Q94147595 description "scienca artikolo" @default.
• Q94147595 description "scientific article published on 5 November 2018" @default.
• Q94147595 description "scientific article published on 5 November 2018" @default.
• Q94147595 description "scientific article published on 5 November 2018" @default.
• Q94147595 description "teaduslik artikkel" @default.
• Q94147595 description "tieteellinen artikkeli" @default.
• Q94147595 description "tudományos cikk" @default.
• Q94147595 description "vedecký článok" @default.
• Q94147595 description "vetenskaplig artikel" @default.
• Q94147595 description "videnskabelig artikel udgivet 5. november 2018" @default.
• Q94147595 description "vitenskapelig artikkel" @default.
• Q94147595 description "vitskapeleg artikkel" @default.
• Q94147595 description "vědecký článek" @default.
• Q94147595 description "wetenschappelijk artikel" @default.
• Q94147595 description "wissenschaftlicher Artikel" @default.
• Q94147595 description "επιστημονικό άρθρο" @default.
• Q94147595 description "мақолаи илмӣ" @default.
• Q94147595 description "наукова стаття, опублікована в листопаді 2018" @default.
• Q94147595 description "научна статия" @default.
• Q94147595 description "научная статья" @default.
• Q94147595 description "научни чланак" @default.
• Q94147595 description "научни чланак" @default.
• Q94147595 description "מאמר מדעי" @default.
• Q94147595 description "مقالة علمية نشرت في 5 نوفمبر 2018" @default.
• Q94147595 description "৫ নভেম্বর ২০১৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
• Q94147595 description "บทความทางวิทยาศาสตร์" @default.
• Q94147595 description "სამეცნიერო სტატია" @default.
• Q94147595 name "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 name "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 type Item @default.
• Q94147595 label "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 label "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 prefLabel "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 prefLabel "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 P1433 Q94147595-E5888D5D-57E7-4031-B421-2201684CA20E @default.
• Q94147595 P1476 Q94147595-AB019604-A8D4-4CF2-81B9-CCBDB8205DA7 @default.
• Q94147595 P2093 Q94147595-1ED07545-64D1-4FF9-86CD-0EF003885DB4 @default.
• Q94147595 P2093 Q94147595-37ED73EE-254E-4199-AA4A-D377C4CECB7D @default.
• Q94147595 P2093 Q94147595-3C201171-E269-4162-A2F6-C6AE2854302A @default.
• Q94147595 P2093 Q94147595-4E3683C7-263A-4F3D-91F9-EF94FF54DB8D @default.
• Q94147595 P2093 Q94147595-4FBAD547-ADA5-4DB6-8CC0-39547890B192 @default.
• Q94147595 P2093 Q94147595-55D8C79D-F3A9-4D8A-B055-7C3666030DBD @default.
• Q94147595 P2093 Q94147595-72B2CE9D-3315-466A-B4F7-C9CC96DD32CF @default.
• Q94147595 P2093 Q94147595-9C3169A6-AF1B-444F-BC10-2993DDB7FC7C @default.
• Q94147595 P2093 Q94147595-BF3FC2D9-829E-42B0-94B7-01B404F61DA4 @default.
• Q94147595 P2093 Q94147595-DF0D8F11-9DAA-41D6-AB87-59A8A9BC135C @default.
• Q94147595 P2093 Q94147595-E480F32A-6AF9-4746-B1B3-42B6E909BE74 @default.
• Q94147595 P2093 Q94147595-EDAA0343-DA76-49E7-8E8B-7295524C75D0 @default.
• Q94147595 P304 Q94147595-6B852B1E-2504-4EF8-AB13-D532E78678CF @default.
• Q94147595 P31 Q94147595-B3671B4F-D0F8-44E0-A874-8B4AF86CDE54 @default.
• Q94147595 P356 Q94147595-3A642766-4779-4E69-B274-C653F077D79B @default.
• Q94147595 P433 Q94147595-2A9F2162-8BC5-4090-AB46-648EC315C35A @default.
• Q94147595 P478 Q94147595-CA0F5E42-7D80-4C9C-8C47-E6731373819D @default.
• Q94147595 P50 Q94147595-F415FB88-9509-496E-896A-6D082BAF9053 @default.
• Q94147595 P577 Q94147595-C5B5EAE4-1F76-4762-86B2-C3D42C64CB4F @default.
• Q94147595 P921 Q94147595-721E3BEC-92D1-4479-AA81-C33E622D95E3 @default.
• Q94147595 P932 Q94147595-D217EB12-6407-448D-AC92-5B6F22F9118F @default.
• Q94147595 P356 NOY148.073 @default.
• Q94147595 P1433 Q15724471 @default.
• Q94147595 P1476 "ACTR-40. A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF MARIZOMIB (MRZ) WITH TEMOZOLOMIDE (TMZ) AND RADIOTHERAPY (RT) IN NEWLY DIAGNOSED WHO GRADE IV MALIGNANT GLIOMA (GLIOBLASTOMA, ndGBM): FULL ENROLLMENT RESULTS" @default.
• Q94147595 P2093 "Benjamin Winograd" @default.
• Q94147595 P2093 "Daniela A Bota" @default.
• Q94147595 P2093 "David Piccioni" @default.
• Q94147595 P2093 "Dawit Aregawi" @default.
• Q94147595 P2093 "Ileana Elias" @default.
• Q94147595 P2093 "Mingyu Li" @default.
• Q94147595 P2093 "Nancy Levin" @default.
• Q94147595 P2093 "Patrick Roth" @default.

• next